Overactive Bladder - Results from #1340

Bladder Symptoms and Attitudes in an Ethnically Diverse Population November 3, 2015

Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction? November 2, 2015

Economic impact of using fesoterodine for the treatment of overactive bladder with urge urinary incontinence in vulnerable elderly population in the United States October 28, 2015

Impact of Loss of Work Productivity in Patients with Overactive Bladder Treated with Antimuscarinics in Spain: Study in Routine Clinical Practice Conditions October 28, 2015

Conjoint Urological Society of Australia and New Zealand (USANZ) and Urogynaecological Society of Australasia (UGSA) Guidelines on the management of adult non-neurogenic overactive bladder October 28, 2015

Use of uroflow parameters in diagnosing an overactive bladder-Back to the drawing board October 28, 2015

Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3-adrenoceptor activation and α1-adrenoceptor blockade. October 28, 2015

How should we address the diagnosis of overactive bladder in women? October 26, 2015

Lower Urinary Tract Symptoms and Aging: The Impact of Chronic Bladder Ischemia on Overactive Bladder Syndrome October 21, 2015

The Functional Effects of Cigarette Smoking in Women on the Lower Urinary Tract October 21, 2015

Comparison of solifenacin and fesoterodine in treatment of overactive bladder October 20, 2015

A quantitative benefit-risk assessment approach to improve decision making in drug development: Application of a multi-criteria decision analysis model in the development of combination therapy for overactive bladder October 20, 2015

Coping with patients suffering from overactive bladder: experiences of family caregivers in Hong Kong October 20, 2015

The efficacy of different doses of solifenacin in elderly patients after treating a urinary tract infection October 20, 2015

The Role of Urodynamics in Elderly Patients October 20, 2015

Translational Research and Functional Changes in Voiding Function in Older Adults October 20, 2015

Urodynamic findings in women with refractory overactive bladder symptoms October 13, 2015

The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial October 13, 2015

The safety and efficiency of onabotulinumtoxinA for the treatment of overactive bladder: a systematic review and meta-analysis October 13, 2015

FDA Grants Chronic Tibial Nerve IDE Approval For World’s Smallest Wireless System to Alleviate OAB Symptoms October 9, 2015

Page 68 of 122